Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cancers|August 28, 2025
Cohesin Loading Factor NIPBL Is Essential for MYCN Expression and MYCN-Driven Oncogenic Transcription in NeuroblastomaJee-Youn Kang, Kaitlyn A Tremble, Philip Homan, et al.
Chemistry & Biology|April 29, 2014
Validating fragment-based drug discovery for biological RNAs: lead fragments bind and remodel the TPP riboswitch specificallyKatherine Deigan Warner, Philip Homan, Kevin M Weeks, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 17, 2017
Association of Increased F4/80high Macrophages With Suppression of Serum-Transfer Arthritis in Mice With Reduced FLIP in Myeloid CellsQi-Quan Huang, Robert Birkett, Renee E Doyle, et al.
Biorxiv : the Preprint Server for Biology|June 21, 2024
Mechanistic Analysis of Riboswitch Ligand Interactions Provides Insights into Pharmacological Control over Gene ExpressionShaifaly Parmar, Desta Doro Bume, Colleen Conelly, et al.
Journal for Immunotherapy of Cancer|November 18, 2024
Adoptive transfer of membrane-restricted IL-12-TCR T cells promotes antigen spreading and elimination of antigen-negative tumor variantsLing Zhang, Scott M Norberg, Farrah Karimipour, et al.
Nature Communications|September 17, 2024
Mechanistic analysis of Riboswitch Ligand interactions provides insights into pharmacological control over gene expressionShaifaly Parmar, Desta Doro Bume, Colleen M Connelly, et al.
Frontiers in Immunology|December 13, 2023
Rapid transient and longer-lasting innate cytokine changes associated with adaptive immunity after repeated SARS-CoV-2 BNT162b2 mRNA vaccinationsMargherita Rosati, Evangelos Terpos, Philip Homan, et al.
Blood Advances|January 14, 2022
Triple combination of BET plus PI3K and NF-κB inhibitors exhibit synergistic activity in adult T-cell leukemia/lymphomaAnusara Daenthanasanmak, Richard N Bamford, Makoto Yoshioka, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
Multimodal Approach for Identification and Validation of Hepatocellular Carcinoma Targets for RadiotheranosticsPhilip Homan, Joon-Yong Chung, Woonghee Lee, et al.
Journal for Immunotherapy of Cancer|February 8, 2023
Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancerCecilia Monge, Changqing Xie, Yuta Myojin, et al.
Pageof 2